OBJECTIVE: The main aim of this collaborative study was to assess the comparability of the most commonly used criteria for mild cognitive impairment (MCI) by comparing the cognitive performance of patients with MCI from the Mayo Clinic (USA) and the Karolinska Institutet (Sweden). METHODS: Standardised neuropsychological test scores were used to compare the two samples from the two institutions with regard to the number of cognitive domains in which performance was below 1.5 SD. Possible predictors for the conversion from MCI to Alzheimer's disease (AD) were assessed. RESULTS: When the two institutions were considered together in the Cox proportional hazard model, the number of affected cognitive domains below 1.5 SD was a significant predictor of time to AD diagnosis with age, education, and APOE epsilon4 genotype entered into the same model as covariates. The number of affected cognitive areas remained as a significant predictor when the institutions were considered separately. The logistic regression model of conversion to AD showed that only tests assessing learning and retention were predictors of developing AD. CONCLUSIONS: Differences in population as well as in methodology of case ascertainment as well as other aspects may account for the observed variability between samples of patients with MCI. The number of impaired cognitive factors at baseline can predict the progression from MCI to AD. Furthermore, tests assessing learning and retention are the best predictors for progression to AD.
OBJECTIVE: The main aim of this collaborative study was to assess the comparability of the most commonly used criteria for mild cognitive impairment (MCI) by comparing the cognitive performance of patients with MCI from the Mayo Clinic (USA) and the Karolinska Institutet (Sweden). METHODS: Standardised neuropsychological test scores were used to compare the two samples from the two institutions with regard to the number of cognitive domains in which performance was below 1.5 SD. Possible predictors for the conversion from MCI to Alzheimer's disease (AD) were assessed. RESULTS: When the two institutions were considered together in the Cox proportional hazard model, the number of affected cognitive domains below 1.5 SD was a significant predictor of time to AD diagnosis with age, education, and APOE epsilon4 genotype entered into the same model as covariates. The number of affected cognitive areas remained as a significant predictor when the institutions were considered separately. The logistic regression model of conversion to AD showed that only tests assessing learning and retention were predictors of developing AD. CONCLUSIONS: Differences in population as well as in methodology of case ascertainment as well as other aspects may account for the observed variability between samples of patients with MCI. The number of impaired cognitive factors at baseline can predict the progression from MCI to AD. Furthermore, tests assessing learning and retention are the best predictors for progression to AD.
Authors: J-C Lambert; L Araria-Goumidi; L Myllykangas; C Ellis; J C Wang; M J Bullido; J M Harris; M J Artiga; D Hernandez; J M Kwon; B Frigard; R C Petersen; A M Cumming; F Pasquier; I Sastre; P J Tienari; A Frank; R Sulkava; J C Morris; D St Clair; D M Mann; F Wavrant-DeVrièze; M Ezquerra-Trabalon; P Amouyel; J Hardy; M Haltia; F Valdivieso; A M Goate; J Pérez-Tur; C L Lendon; M-C Chartier-Harlin Journal: Neurology Date: 2002-07-09 Impact factor: 9.910
Authors: S E Rose; K L McMahon; A L Janke; B O'Dowd; G de Zubicaray; M W Strudwick; J B Chalk Journal: J Neurol Neurosurg Psychiatry Date: 2006-06-05 Impact factor: 10.154
Authors: Dan Mungas; Laurel Beckett; Danielle Harvey; Sarah Tomaszewski Farias; Bruce Reed; Owen Carmichael; John Olichney; Joshua Miller; Charles DeCarli Journal: Psychol Aging Date: 2010-09
Authors: L M Ercoli; G W Small; P Siddarth; V Kepe; S-C Huang; K J Miller; H Lavretsky; S Y Bookheimer; J R Barrio; D H S Silverman Journal: Int J Geriatr Psychiatry Date: 2012-03-01 Impact factor: 3.485
Authors: Joel H Kramer; Adam Nelson; Julene K Johnson; Kristine Yaffe; Shenly Glenn; Howard J Rosen; Bruce L Miller Journal: Dement Geriatr Cogn Disord Date: 2006-08-23 Impact factor: 2.959
Authors: Patria A Hume; Alice Theadom; Gwyn N Lewis; Kenneth L Quarrie; Scott R Brown; Rosamund Hill; Stephen W Marshall Journal: Sports Med Date: 2017-06 Impact factor: 11.136
Authors: Sarah T Farias; Dan Mungas; Bruce R Reed; Danielle Harvey; Deborah Cahn-Weiner; Charles Decarli Journal: Alzheimer Dis Assoc Disord Date: 2006 Oct-Dec Impact factor: 2.703
Authors: Sarah Tomaszewski Farias; Elizabeth Chou; Danielle J Harvey; Dan Mungas; Bruce Reed; Charles DeCarli; Lovingly Quitania Park; Laurel Beckett Journal: Psychol Aging Date: 2013-12
Authors: Ana Luisa Sosa; Emiliano Albanese; Blossom C M Stephan; Michael Dewey; Daisy Acosta; Cleusa P Ferri; Mariella Guerra; Yueqin Huang; K S Jacob; Ivonne Z Jiménez-Velázquez; Juan J Llibre Rodriguez; Aquiles Salas; Joseph Williams; Isaac Acosta; Maribella González-Viruet; Milagros A Guerra Hernandez; Li Shuran; Martin J Prince; Robert Stewart Journal: PLoS Med Date: 2012-02-07 Impact factor: 11.069